Windlas Biotech (NSE:WINDLAS) EPS (Basic) : ₹29.18 (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Windlas Biotech EPS (Basic)?

Windlas Biotech's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ₹7.77. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹29.18.

Windlas Biotech's EPS (Diluted) for the three months ended in Mar. 2025 was ₹7.67. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹28.92.

Windlas Biotech's EPS without NRI for the three months ended in Mar. 2025 was ₹7.67. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 28.92.

During the past 12 months, Windlas Biotech's average EPS without NRIGrowth Rate was 3.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 15.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 26.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, Windlas Biotech's highest 3-Year average EPS without NRI Growth Rate was 40.40% per year. The lowest was 15.10% per year. And the median was 20.00% per year.

Windlas Biotech EPS (Basic) Historical Data

The historical data trend for Windlas Biotech's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Windlas Biotech EPS (Basic) Chart

Windlas Biotech Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

EPS (Basic)

Get a 7-Day Free Trial

8.69

18.58

19.70

27.97

29.19

Windlas Biotech Quarterly Data
	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															8.17	6.47	7.49	7.45	7.77

Windlas Biotech EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Windlas Biotech's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(609.94	-	0)	/	20.896
	=	29.19

Windlas Biotech's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(162.81	-	0)	/	20.959
	=	7.77

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹29.18

Windlas Biotech (NSE:WINDLAS) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Windlas Biotech EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Windlas Biotech's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Windlas Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Windlas Biotech Ltd (NSE:WINDLAS) » Definitions » EPS (Basic)

Traded in Other Exchanges

543329:India

Address

Golf Course Extension Road, 705-706, Vatika Professional Point, Sector-66, Gurgaon, HR, IND, 122 001

Website

https://www.windlas.com

Windlas Biotech Ltd is a pharmaceutical formulation contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.

Windlas Biotech Headlines

No Headlines